Public signalCompany raiseAuto-indexed · Unverified

NovaBay Pharmaceuticals, Inc. raised $226K

NovaBay Pharmaceuticals, Inc.· EMERYVILLE, US· Pharmaceuticals· Filed Jun 28, 2024

NovaBay Pharmaceuticals, Inc. reported raising capital. Based in EMERYVILLE, CALIFORNIA, US. First sale reported 2024-06-14. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.

Raised
$225,953
Confidence90%
Raised
$225,953
Investors
5
Jurisdiction
DELAWARE

On the record

Location
EMERYVILLE, US
Sector
Pharmaceuticals
Record type
Company raise
Stage
Reported raised
Amount raised
$225,953
Target amount
$225,953
Filing date
Jun 28, 2024
Issuer type
operating company

Gaps in the record

  • Valuation and deal terms are not on the public record
  • No company website on record
  • Investors are not disclosed
  • Not yet claimed or verified by the company

Filing details

Jurisdiction of incorporation
DELAWARE
Industry group
Pharmaceuticals
Number of investors
5
Includes non-accredited investors
No
Revenue range
Decline to Disclose
Total offering amount
$225,953
Amendment
No

People named on this filing

Officers, directors, managers and entities listed in the public filing.

Sources & provenance

Operating company sold 225,953 USD under Reg D.

View original filing (SEC EDGAR Form D)

Automatically indexed from SEC EDGAR Form D · filing dated Jun 28, 2024. Details beyond the filing have not been verified.

Tags

USCompanyPharmaceuticals$100K – $1MCompany Raise

Are you associated with NovaBay Pharmaceuticals, Inc.?

This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.

Claim this record